Detection and Characterisation of Heteroresistant Vancomycin Intermediate Staphylococcus aureus (hVISA) using Phenotypic and Genotypic Methods

被引:2
|
作者
Selvabai, Alice Peace [1 ]
Sattar, Shameem Banu Abdul [1 ]
Jayaraman, Perumal [1 ]
Shanmugam, Priyadarshini [1 ]
机构
[1] Chettinad Acad Res & Educ, Chettinad Hosp & Res Inst, Dept Microbiol, Chennai, Tamil Nadu, India
关键词
Drug resistant gram positive cocci; Methicillin resistance; Multidrug resistance; Vancomycin resistance; AGR DYSFUNCTION; RESISTANCE; SUSCEPTIBILITY;
D O I
10.7860/JCDR/2019/41127.12868
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Vancomycin remains the drug of choice to treat infections caused by Methicillin Resistant Staphylococcus aureus (MRSA). Frequent therapeutic failures arise due to the emergence of strains with reduced susceptibility to vancomycin and difficulty in detecting these isolates. Therefore, improvements in screening and confirmatory tests to detect these isolates are required. Aim: To detect heteroresistant Vancomycin Intermediate Staphylococcus aureus (hVISA) isolates among Methicillin Resistant Staphylococcus aureus (MRSA) and Methicillin Sensitive Staphylococcus aureus (MSSA) obtained from various clinical samples and to study the phenotypic and genotypic charecteristics of these strains. Materials and Methods: This study was carried out in the Department of Microbiology, Chettinad Hospital and Research Institute, Kelambakkam, Chennai, Tamil Nadu, India. A total of 468 non-duplicate S.aureus strains obtained from various clinical samples during a period of two years from September 2014 to November 2016 were included in the study. MRSA isolates and hVISA/VISA isolates were detected by screening and confirmatory methods (MRSA screen by cefoxitin disc, hVISA/VISA screen by brain heart infusion agar with 6 mu g vancomycin and hVISA/VISA confirmation by PAP-AUC method). Agr polymorphism in hVISA/VISA was analysed by duplex PCR. Accessory gene regulator (Agr) dysfunction in these strains was studied by their colony spreading property in soft agar and autolytic property by Triton X-100 induced lysis. The results were analysed using IBM SPSS (version 21.0) software. Results: Out of 468 S.aureus strains, 114 (24%) strains were detected as MRSA and 33 (7.0%) were hVISA/VISA strains. Among MRSA detected, 11 (9.5%) strains were confirmed as hVISA/VISA. All hVISA/VISA isolates showed reduction in autolytic activity. Colony spreading property was appreciated in 13 (39%) of these isolates. Out of the 33 hVISA/VISA strains, majority belonged to agr I, III and II and the least number of isolates belonged to agr IV. Conclusion: It was concluded that hVISA/VISA strains have diverse virulence properties and are detected in both MRSA and MSSA strains. Therefore. surveillance of these strains among S.aureus isolates having vancomycin MIC's <= 1.5 mu g/mL in laboratory settings is needed.
引用
收藏
页码:DC01 / DC05
页数:5
相关论文
共 50 条
  • [1] Effects of Linezolid on Suppressing Heteroresistant Vancomycin Subpopulations among Heteroresistant Vancomycin Intermediate Staphylococcus aureus (hVISA)
    Alshami, Issam
    Alharbi, Ahmed Eid
    Abdel-Aziz, Nada Abdelmohsen
    Ibrahim, Kawther Mohammed
    Eltahlawi, Rehab Abdallah
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2014, 8 : 215 - 220
  • [2] Emergence of heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) infection in Western Australia
    Murray, RJ
    Sieunarine, K
    Ward, PB
    Pearman, JW
    MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (04) : 227 - 228
  • [3] Detection of heteroresistant vancomycin intermediate Staphylococcus aureus in bloodstream infection
    Harigaya, Y.
    Huang, V.
    Mylotte, J.
    Lesse, A.
    Tsuji, B.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S63 - S63
  • [4] Heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in prosthetic joint infections: a case series and review
    Sivakumar, Brahman
    Chaudhuri, Alex
    Vijaysegaran, Praveen
    ORTHOPEDIC RESEARCH AND REVIEWS, 2012, 4 : 27 - 32
  • [5] Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a tertiary care institution in Singapore
    Fong, R. K. C.
    Low, J.
    Koh, T. H.
    Kurup, A.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2009, 28 (08) : 983 - 987
  • [6] Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a tertiary care institution in Singapore
    R. K. C. Fong
    J. Low
    T. H. Koh
    A. Kurup
    European Journal of Clinical Microbiology & Infectious Diseases, 2009, 28
  • [7] Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus among Methicillin-Resistant Staphylococcus aureus
    Chaudhary, Bajarangi Lal
    Bisht, Dakshina
    Faujdar, Sameer
    ASIAN JOURNAL OF PHARMACEUTICAL RESEARCH AND HEALTH CARE, 2022, 14 (01) : 16 - 20
  • [8] Etest Methods for Screening Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) strains
    Min Young Lee
    Woo In Lee
    Myeong Hee Kim
    So Young Kang
    Young Jin Kim
    Current Microbiology, 2020, 77 : 3158 - 3167
  • [9] Molecular epidemiology of heteroresistant vancomycin-intermediate Staphylococcus aureus in Brazil
    de Oliveira Silveira, Alessandro Conrado
    da Cunha, Gabriela Rosa
    Caierao, Juliana
    Mendes de Cordova, Caio Mauricio
    d'Azevedo, Pedro Alves
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2015, 19 (05): : 466 - 472
  • [10] Investigation of heteroresistant vancomycin intermediate Staphylococcus aureus among MRSA isolates
    Gazel, Deniz
    Erinmez, Mehmet
    Manay, Ayse Buyuktas
    Zer, Yasemin
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2021, 15 (01): : 89 - 94